đź“‹ FDA Reference
vascular access port cath cat vp-xxx vasport ser
Gish Biomedical
Summary: The Vascular Access Port Cath Cat VP-XXX Vasport Ser is a medical device used for long-term venous access. It is commonly utilized by oncologists and other specialists for administering chemotherapy or other intravenous treatments.
FDA Clearance Information
Pathway
510K
Number
K873035 ↗
Decision Date
September 25, 1987
Product Code
DQY
Device Class
Class 2
Evidence
0 studies
The Vascular Access Port Cath Cat VP-XXX Vasport Ser was cleared through the FDA 510(k) pathway on September 25, 1987. It is manufactured by Gish Biomedical and is classified as a Class 2 device.
What It Is
The Vascular Access Port Cath Cat VP-XXX Vasport Ser is a vascular access port designed for long-term venous access. It consists of a small reservoir implanted under the skin, connected to a catheter that enters a vein. This device allows for repeated access to the venous system for the delivery of medications, fluids, or for blood sampling, minimizing the need for repeated needle sticks.
Clinical Applications
This device is commonly used in oncology for the administration of chemotherapy. It is also used in hematology for patients requiring frequent blood transfusions or blood sampling. The device is suitable for both inpatient and outpatient settings, and is typically used in adult and pediatric populations requiring long-term intravenous therapy.
Indications for Use
The FDA indications for this device include providing long-term venous access for patients who require frequent intravenous treatments. It is particularly beneficial for patients undergoing chemotherapy or other chronic infusion therapies.
Practical Considerations
The device is available in various sizes to accommodate different patient anatomies. It is compatible with standard infusion sets and requires surgical implantation. Clinicians should be trained in the proper technique for accessing and maintaining the port to prevent complications such as infection or thrombosis.
Related Literature
The linked study titled 'Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia' explores the use of ascorbic acid in combination with chemotherapy. Although the abstract is not available, the study likely investigates the efficacy and safety of this combination treatment. Limitations include the lack of detailed results and the absence of a publication year, which may affect the study's relevance.
Frequently Asked Questions
What is Vascular Access Port Cath Cat VP-XXX Vasport Ser used for?
It is used for long-term venous access to administer medications, fluids, or for blood sampling.
What specialties typically use this device?
Oncology, hematology, and any specialty requiring long-term intravenous therapy use this device.
What are the FDA-cleared indications?
The device is indicated for providing long-term venous access for patients needing frequent intravenous treatments.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.